SGO1 and Alzheimer disease: Mitochondrial aconitase (aco2) expression in human AD with mild cognitive impairment was reported to be lower (Khodagholi, Shaerzadeh, & Montazeri, 2018; Mangialasche et al., 2015), while Sgo1−/+ mice showed a possible compensatory increase.